Top Markets
Coin of the day
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940
Pozycja w akcjach #519
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Cena akcji
$1,071.12
Kapitalizacja rynkowa
$49.58B
Zmiana (1 dzień)
-3.73%
Zmiana (1 rok)
-5.56%
Kraj
KR
Handel Samsung Biologics Co.,Ltd. (207940)

Kategoria

Historia stopy dywidendy dla Samsung Biologics Co.,Ltd. (207940)
Stopa dywidendy (TTM) dla Samsung Biologics Co.,Ltd. (symbol akcji: 207940) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Samsung Biologics Co.,Ltd. (207940) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
0.00%
US
0.00%
NL
0.00%
CH
0.65%
BE
3.46%
AU